News
First Investment: 2018
EXIT - Acquisition (MindMed: MNMD)
HealthMode built a platform that used AI to increase the speed and precision of patient monitoring during clinical trials. MindMed acquired HealthMode in 2021.
News & Insights
Explore Companies
Valar Labs
Using AI models trained on digital pathology images to help oncologists make smarter cancer treatment decisions
DVLP Medicines
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing
Noetik
Using self-supervised machine learning to map the circuit diagram of tumor biology and develop new immunotherapies for cancer
Remedy Robotics
Vascular intervention without borders